re.Mind Capital is a specialist venture capital fund dedicated to mental health, neurological health, brain-computer interfaces, digital health, and new pharma. It is the mental health VC arm of entrepreneur Christian Angermayer and his family office, Apeiron Investment Group.
67% of their portfolio is in Healthcare. Average disclosed round size is $18.2M (across 7 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Team
MD
Max de Vere
Co-founder and partner
JH
Jan Hardorp
Partner
JB
Joao Barbosa da Silva
Investor
KJ
Katherine Jones
Investor
CA
Christian Angermayer
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Anna Health | Unknown | $9.3M | Nov 2024 |
| MMotif Neurotech | Unknown | $18.8M | Jan 2024 |
| Anna Health | Unknown | $9.3M | Jan 2024 |
 Precision Neuroscience | Series B | $41M | Jan 2023 |
 Sensorium Therapeutics | Series A | $30M | Nov 2022 |
 iLoF | Seed | — | Jul 2022 |
| NNeumora Therapeutics, Inc. | Series A | — | Oct 2021 |
 Blackrock Neurotech | Seed | $10M | May 2021 |
 Anna | Unknown | $9.3M | — |
Top Co-Investors
GreyMatter Capital3 shared
Virtue3 shared
Watershed Ventures3 shared
Mubadala Ventures2 shared
Alter Global1 shared
M121 shared
Scale Venture Partners1 shared
Quiet Capital1 shared
Berggruen Holdings1 shared
Lunar Ventures1 shared
Faber1 shared
Alumni Ventures1 shared
Steadview Capital1 shared
B Capital1 shared
Draper Associates1 shared
Palo Santo1 shared
CU Healthcare Innovation Fund1 shared
Route 66 Ventures1 shared
Versant Ventures1 shared
Dolby Family Ventures1 shared
Last updated: 8 September 2026